Open AccessEffects of liraglutide compared with placebo on events of acute gallbladder or biliary disease in patients with type 2 diabetes at high risk for cardiovascular events in the LEADER randomized trial
Author(s) -
M.A. Nauck,
M.L.M. Ghorbani,
E. Kreiner,
H.A. Saevereid,
J.B. Buse,
LEADER Publication Committee on behalf of the LEADER Trial Investigators
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/1h1y-s837
Subject(s) - liraglutide , medicine , placebo , type 2 diabetes , diabetes mellitus , randomized controlled trial , gastroenterology , disease , gallbladder , biliary disease , endocrinology , pathology , alternative medicine